Novavax Inc (NVAX): who owns it and who trades it
As of Nov 16, 2026, no open-market insider purchases or sales of NVAX were reported in the last 12 months. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Novavax
From the latest filingsOverall: more selling than buying. Famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NVAX
265 funds and institutions reported NVAX shares worth $1.1B at the end of Q2 2026, about 72% of the company. The largest holder is Shah Capital Management with 8.6%.
Funds and institutions (13F) 72%Everyone else 28%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Shah Capital Management | 14.17M | 8.61% | $133M | -5% |
| BlackRock, Inc. | 13.95M | 8.48% | $131M | +9% |
| State Street Corp | 11.74M | 7.14% | $111M | +31% |
| Vanguard Portfolio Management LLC | 7.61M | 4.63% | $71.7M | +6% |
| Vanguard Capital Management LLC | 7.26M | 4.41% | $68.4M | +2% |
| Sanofi | 6.88M | 4.18% | $64.8M | No change |
| D. E. Shaw & Co., Inc. | 5.65M | 3.44% | $53.2M | -27% |
| Geode Capital Management, LLC | 4.21M | 2.56% | $39.6M | +8% |
| Two Sigma Investments, LP | 4.09M | 2.49% | $38.5M | +565% |
| Coatue Management LLC | 3.84M | 2.33% | $36.1M | No change |
| Bank of America Corp | 3.42M | 2.08% | $32.2M | -49% |
| Goldman Sachs Group Inc | 3.01M | 1.83% | $28.3M | +113% |
| UBS Group AG | 1.87M | 1.14% | $17.6M | -58% |
| Millennium Management LLC | 1.77M | 1.08% | $16.7M | -54% |
| Citadel Advisors LLC | 1.70M | 1.03% | $16M | +51% |
| Allianz Asset Management GmbH | 1.58M | 0.96% | $14.9M | -15% |
| Northern Trust Corp | 1.45M | 0.88% | $13.6M | -4% |
| TSP Capital Management Group, LLC | 1.42M | 0.86% | $13.4M | – |
| Charles Schwab Investment Management Inc | 1.35M | 0.82% | $12.7M | -2% |
| Sixth Street Partners Management Company, L.P. | 1.35M | 0.82% | $12.7M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
No NVAX insider reported an open-market purchase or sale in the last 12 months.
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NVAX short interest
Very high short interest. 28.1% of NVAX shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 2%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 46.33M NVAX shares were sold short, 28.1% of the shares outstanding, down 2.2% from the report before. At the average daily volume of 6.09M shares, buying them all back would take about 7.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 46.33M | 28.09% | -2% | 6.09M | 7.6 |
| Oct 15, 2026 | 47.35M | 28.71% | +3% | 10.92M | 4.3 |
| Sep 30, 2026 | 46.05M | 27.92% | -8% | 5.71M | 8.1 |
| Sep 15, 2026 | 49.88M | 30.24% | +2% | 5.37M | 9.3 |
| Aug 31, 2026 | 48.78M | 29.58% | +3% | 5.66M | 8.6 |
| Aug 14, 2026 | 47.49M | 28.79% | +4% | 3.38M | 14.0 |
| Jul 31, 2026 | 45.66M | 27.68% | +4% | 2.75M | 16.6 |
| Jul 15, 2026 | 43.82M | 26.65% | -4% | 3.84M | 11.4 |
| Jun 30, 2026 | 45.81M | 27.86% | +2% | 4.94M | 9.3 |
| Jun 15, 2026 | 45.11M | 27.43% | -2% | 4.18M | 10.8 |
| May 29, 2026 | 45.97M | 27.95% | +2% | 5.87M | 7.8 |
| May 15, 2026 | 45.28M | 27.54% | -8% | 7.13M | 6.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Novavax company events
Novavax filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Oct 29, 2026AnnouncementOn October 28, 2026 Sanofi Pasteur Inc. dosed the fifth patient in its Phase 3 influenza-COVID-19 combination vaccine trial in the European Union, utilizing the Company’s COVID-19 component. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jun 23, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 20, 2026AgreementEntry into Material Definitive Agreements. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Novavax financials
Famous investors that hold NVAX
5 of the 50 well-known investors we track reported holding NVAX in their latest 13F filing. The largest position is Philippe Laffont's, worth $41.5M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Philippe Laffont · Coatue Management | Q3 2026 | 3.84M | $41.5M | 0.1% | No change |
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.78M | $30.1M | 0.0% | +64% |
| Israel Englander · Millennium Management | Q3 2026 | 1.06M | $11.5M | 0.0% | -40% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 47,514 | $514K | 0.0% | -62% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 43,200 | $467K | 0.0% | -91% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named NVAX in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.4% |
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 5.4% |
| Oct 16, 2026 | Shah Capital Management | 13D/A | 6.4% |
| Oct 16, 2026 | Shah Capital Management | 13D/A | 6.4% |
| Oct 16, 2026 | Shah Capital Management | 13G | 6.4% |
| Oct 16, 2026 | Shah Capital Management | 13G | 6.4% |
Questions about Novavax Inc (NVAX) stock
Who owns the most NVAX stock?
The largest reported owner of Novavax Inc (NVAX) is Shah Capital Management, with 8.6% of the company. In total, 265 funds and institutions reported holding NVAX at the end of Q2 2026, together about 72% of the shares. See the largest owners.
Are NVAX insiders buying or selling?
No NVAX insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.
What is the short interest in NVAX?
As of Oct 30, 2026, 46.33M NVAX shares were sold short, 28.1% of the shares outstanding, down 2.2% from the report before. At the average daily volume of 6.09M shares, buying them all back would take about 7.6 trading days (days to cover). See the history.
Which famous investors hold NVAX?
5 of the 50 well-known investors we track reported NVAX in their latest 13F filing, including Philippe Laffont, Ken Griffin, Israel Englander. The largest position is worth $41.5M. See all holders.
Executive pay
Novavax's chief executive was paid a total of $8.9M for the year ended Dec 31, 2025. In the last 12 months, Novavax's executives and directors bought no stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.